Navigation Links
Repeated in Biological Technology

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... in a P value of 0.005. A pre-specified repeated measures analysis of the primary endpoint was ... time course of treatment effect. An exploratory repeated measures analysis of ranked change from baseline, ... the relative reductions in LS means from the repeated measures analysis were 46% and 29%, respectively. ...

CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies

... infections. As a result, patients may face repeated rounds of antibiotics or, in some severe cases of PID, be hospitalized repeatedly for treatment. repeated infections can lead to organ damage, which, over ... reactions tended to decrease substantially after repeated use. The most frequent adverse events reported ...

Five Questions About Protopic (tacrolimus) Ointment

... Protopic should be used for short periods and, if needed, treatment may be repeated after breaks. Protopic can be a valuable part of an overall treatment ... treat moderate to severe eczema for short periods, and, if needed, may be repeated with breaks in between.(4) After first-line treatments, or when those ...

Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

... number 97) "A Phase III, Multicenter, Open-label, Prospective, repeated Dose, Multi Day Randomized Controlled Study of the Safety of IV Acetaminophen in Adults" (Study 351; abstract number 96) "Pediatric Safety of repeated Doses of IV Acetaminophen" (Study 352; abstract number 58) ...

Pharmasset to Present at Canaccord Adams Conference

... our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not ...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

... to require only one or two physician-administered treatments, in contrast to most diabetic wound healing agents or devices in use that require repeated administrations over a long term (weeks to months). Based on recently announced advancements, Excellarate is also expected to be re-formulated as an ...

SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia

... symptoms as measured by change from baseline to Day 365 in the NSA-16 total score, the primary endpoint of the study. By using a mixed model for repeated measures (MMRM), least square mean changes in the NSA-16 total score were -15.8 for SAPHRIS vs. -11.0 for olanzapine (P=0.015). Full results of the ...

Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies

... ABOUT RESPIRATORY SYNCYTIAL VIRUS RSV is the most commonly identified cause of lower respiratory tract illnesses in infants and young children. repeated infections occur throughout life causing moderate to severe cold-like symptoms. More severe lower respiratory tract disease is also seen in elderly ...

Nanopillars promise cheap, efficient, flexible solar cells

... to make a bendable device, which could be flexed with only marginal effect on performance and no degradation of performance after repeated bending. "There are lots of ways to improve 3-D nanopillar photovoltaics for higher performance, and ways to simplify the fabrication process as ...

Sorenson Molecular Genealogy Foundation to Protect Archived DNA Using Biomatrica's Room Temperature Storage

... biological materials since my wife has lost an enormous number of samples in defective freezers, and I have seen decreased sample quality through repeated freeze/thaw cycles, even when stored at minus 80 degrees," said Rolf Muller, Ph.D., president and CSO of Biomatrica. "Companies with biobanks, such ...

High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu

... Evaluation of Medical Devices. Tests were conducted to evaluate cytotoxicity to cells, skin irritation on contact, and skin sensitization after repeated contact. No cytotoxicity, irritation or incidence of sensitization was observed. By complying with the European Community's Medical Devices ...

BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests

... one test sample - be possible," explained Emmanuel Bois, Chief Executive Officer of Cezanne. In daily routine this would spare patients the burden of repeated blood withdrawal and in the same time save time and costs for the hospital. Lumi4(R) complexes are a new class of fluorescent-metal lanthanide ...

Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference

... successfully as a drug or at all; research & development risks, including the risk that early research and development results may not be repeated in later research and development; the risk that analytical methods developed to date may require future modification or additional methods may need ...

Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia

... received two prior treatments with chemotherapy (2nd salvage treatment). A dose of 2000 mg/m2/day was given as continuous infusion for five days. One repeated course was allowed in order to attain remission. Elacytarabine showed a favourable safety profile and clinical responses have been reported ...

Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight

... Evaluation of Medical Devices. Tests were conducted to evaluate cytotoxicity to cells, skin irritation on contact, and skin sensitization after repeated contact. No cytotoxicity, irritation or incidence of sensitization was observed. The BioMask is the first in a series of new products in ...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

... therapeutic drug levels; and to reduce side effects, including nausea associated with high peak levels of exenatide exposure observed with repeated injections. About ITCA 650 ITCA 650 therapy for type 2 diabetes consists of DUROS continuous delivery of exenatide. The DUROS delivery ...

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

... in the comparator arm. The median doxorubicin equivalent dose at the end of therapy was 513 mg/m2 (with a range of 115 mg/m2 to 1003mg/m2). Data from repeated evaluations of Left Ventricular Ejection Fraction ("LVEF") by MUGA (Multi Gated Acquisition Scan) scan demonstrated no consistent dose related ...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

... aggressive form of brain cancer, were also presented(3) . Fifty-six patients were enrolled with daily oral doses of AT-101 given for 21 of 28 days in repeated cycles. The treatment was well tolerated, with a low incidence of serious adverse events and no unique central nervous system toxicities. Responses ...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

... therapeutic drug levels; and to reduce side effects, including nausea associated with high peak levels of exenatide exposure observed with repeated injections. About ITCA 650 ITCA 650 therapy for type 2 diabetes consists of DUROS continuous delivery of exenatide. The DUROS delivery ...

Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452

... infarctions. The costs to society attributable to the prevalence of heart failure are high, especially as many chronic heart failure patients suffer repeated acute episodes. Despite currently available therapies, readmission rates for heart failure patients over the age of 65 are as high as 42 percent ...

NeurogesX Receives European Commission Approval for Qutenza(TM)

... not indicated for adults who have diabetes as there is only limited experience with Qutenza in patients with Painful Diabetic Neuropathy (PDN), and repeated treatments with Qutenza in patients with PDN have not been studied. NeurogesX anticipates that Qutenza will be marketed in the European Union ...

Pharmasset Reports Fiscal Second Quarter 2009 Financial Results

... our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not ...

NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting

... data from almost 300 patients evaluated in two open-label, 1-year repeat treatment studies appeared to show no detrimental neurologic effects of repeated treatment with Qutenza. The most common adverse reactions observed in these clinical trials were transient application site reactions (pain and/or ...

Scientists moving closer to 'artificial noses'

... oscillations were measured by two other electrodes. "We created this setup using etching techniques," reports Weig. "But this was easily done even repeated ten thousand times on a chip. The only thing to do now is to make sure the strings can be individually addressed by a suitable circuit." All in all, ...

AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver

... leads to a higher Cmax and trough values after administration of comparable doses. Conclusions - AEZS-112 was well tolerated over repeated treatment courses; - So far, a maximum tolerated dose for weekly dosing has not been defined; and - Prolonged courses of stable disease ...

Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza

... allow the first inhalation, creating turbulence within the dose chamber and drawing the dry powder into the lung of the patient. The process is then repeated for the second dose chamber, as the shuttle is moved to the opposite side to permit another inhalation to take place. Visit ...

Batman Teams with Senator Katherine Laforge to Help Free America from OPEC

... I found it interesting when talking to Mr. Batman that he expressed some of the same concerns, basically that a great deal of misinformation is repeated so often that these untruths becomes reality to much of the public.” When Hearne presented Kent Batman with a copy of his book , he had a ...

New study indicates smallpox vaccination effective for decades

... be vaccinated, leaving another dose available for someone else. Current recommendations relating to smallpox vaccination has been that people with repeated exposure to smallpox, for example travelers to endemic areas, should be revaccinated every five years. This study suggests that such reimmunizations ...

Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value

... ) * Approximate net cash per share liquidation value at time of negative binary event. This repeated lost value and waste is a key reason why we believe downside protection is so important for all stockholders. We want to prevent Avigen from joining ...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

... Respiratory Syncytial Virus RSV is the most commonly identified cause of lower respiratory tract infection in infants and young children with repeated infections causing moderate to severe cold-like symptoms throughout life. High risk individuals (including the elderly over age 65 years, people with ...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

... 2007 primarily due to gains related to the sale of non-core product rights of $115.7 million recognized in the fourth quarter of 2007 which were not repeated in 2008. Cash inflow from operating activities for the three months to December 31, 2008 increased to $274.6 million (2007: $66.6 million). ...

Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask

... Evaluation of Medical Devices. Tests were conducted to evaluate cytotoxicity to cells, skin irritation on contact, and skin sensitization after repeated contact. No cytotoxicity, irritation or incidence of sensitization was observed. Filligent will unveil the BioMask to the world's leading ...

Carbon nanotube avalanche process nearly doubles current

... fields," said Pop, who also is affiliated with the Beckman Institute and the Micro and Nanotechnology Laboratory at the U. of I. "We performed repeated measurements, obtaining currents of up to 40 microamps, nearly twice those of previous reports." By inducing very high electric fields in the ...

Pharmasset Reports Fiscal First Quarter 2009 Financial Results

... our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not ...

Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock

... our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not ...

New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns

... factors, including, but not limited to: risks related to our belief that the positive results and clinical outcomes achieved in this study will be repeated in other studies, and risks related to our assumption that Masimo pulse oximetry technologies and devices will deliver a sufficient level of ...

Panda Ethanol's Hereford, Texas Subsidiary Files Voluntary Chapter 11

... one of the major syndicate banks had informed Societe Generale that it would not fund its share of further borrowing requests for the project. After repeated conversations with the syndicate and an unsuccessful attempt to secure debtor-in-possession financing, the Hereford subsidiary's management concluded ...

Researchers: Molecular forklifts overcome obstacle to 'smart dust'

... is needed because the assay, which uses pairs of antibodies to latch onto target contaminants and the markers that give away their presence, requires repeated flushing with water. That requires pumps, which need power. To miniaturize the system, it's necessary to build miniature pumps and batteries. But ...

Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients

... our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not ...

New study indicates smallpox vaccination effective for decades

... be vaccinated, leaving another dose available for someone else. Current recommendations relating to smallpox vaccination has been that people with repeated exposure to smallpox, for example travelers to endemic areas, should be revaccinated every five years. This study suggests that such reimmunizations ...
Other Contents
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here before: ... but can,t remember your password, site key or the answer ... your first grade teacher? Today, Hoyos ... app that will finally put an end to the ... 1U TM . 1U leverages a user,s smartphone to ...
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2
(Date:12/24/2014)... 2014 The federal court overseeing ... blood thinner caused life-threatening episodes of internal bleeding ... for the proceeding, Bernstein Liebhard LLP reports. According ... plans to select lawyers to serve as Liaison ... appointing a Plaintiffs’ Steering Committee, which will coordinate ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Mike ... sat down with Derek Fenwick, PT, MBA, GCS, ... that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, the ... XVIII of the Social Security Act to standardize post-acute ...
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- Hepatitis C infection does not ... a new study. Treatment advances have made it possible ... develop memory and thinking problems, mood swings and other types ... It,s believed that long-term infections with other viruses -- ... the brain. One of the prime suspects has been the ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... start smoking or drinking with each additional symptom they ... new research suggests. "Our findings underscore the ... use as [these] children approach adolescence," said study author ... Group, which is part of Cincinnati Children,s Hospital. "This ...
(Date:12/24/2014)... For chic ladies, new fashionable outfits are necessary when heading ... Wish List, Angeldress.co.uk has chosen some of their ... holiday wardrobe by launching a promotion on its cheap clothes ... of 80% off, like a cheap suit. , “All items ... wedding dresses are among the hottest items in the global ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2
Other TagsOther Tags